Genetic Variation of the Kalirin Gene is Associated with ICAS in the Chinese Population
Intracranial atherosclerotic stenosis (ICAS) is one of the most common causes of ischemic stroke (IS), especially in recurrent patients. Several studies have demonstrated an intimate association between the genetic mutation of the KALRN gene and IS. The main aim of this study was to clarify the relationship between three single nucleotide polymorphisms (SNPs) of KALRN and ICAS in a northern Chinese population and further explore the underlining mechanism. The relationship between each SNP and ICAS and the related components were examined in five models (co-dominant, dominant, recessive, heterozygous, and additive). Multivariate logistic regression models were applied and adjusted for 10,000 permutation tests. Haplotype regression analysis was performed to determine the associations between haplotypes and the severity of ICAS. qRT-PCR was used to confirm the mRNA level of Kalirin. SNP rs6438833 of the Kalirin gene in the additive model was associated with ICAS (OR = 1.642, 95%CI: 1.129-2.388, PDom = 0.048). After performing 10,000 permutations, the result showed a trend toward statistical significance (Pper = 0.048). Haplotypes of the KALRN gene were not significantly associated with ICAS (global significance, p = 0.090). qRT-PCR showed that the expression of KALRN 9 in IS patients was almost threefold the control group (p < 0.0005). SNPs of the KALRN gene are associated with ICAS in the northern Chinese population.
KeywordsIschemic stroke Intracranial atherosclerotic stenosis KALRN SNP
The study was supported by the National Natural Science Foundation of China (Grant No. 81527803, 81420108018). We would like to express our appreciation to the participants of the study for their participation and full cooperation.
Compliance with Ethical Standards
Conflicts of Interest
None of the authors had any conflict of interest.
- Bevan S, Traylor M, Adib-Samii P, Malik R, Paul NL, Jackson C et al (2012) Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke 43(12):3161–3167. https://doi.org/10.1161/STROKEAHA.112.665760 CrossRefPubMedGoogle Scholar
- Hayashi-Takagi A, Araki Y, Nakamura M, Vollrath B, Duron SG, Yan Z et al (2014) PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence. Proc Natl Acad Sci U S A 111(17):6461–6466. https://doi.org/10.1073/pnas.1321109111 CrossRefPubMedPubMedCentralGoogle Scholar
- Iasevoli F, Tomasetti C, Buonaguro EF, de Bartolomeis A (2014) The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment. Curr Neuropharmacol 12(3):219–238. https://doi.org/10.2174/1570159X12666140324183406 CrossRefPubMedPubMedCentralGoogle Scholar
- Li X, Wang Z, Liu Y, Zhang R, Guo X, Liu W et al (2014) Association of imaging classification of intracranial cerebral atherosclerotic vascular stenosis in ischemic stroke and renalase gene polymorphisms. J Mol Neurosci 52(4):461–466. https://doi.org/10.1007/s12031-013-0110-9 CrossRefPubMedGoogle Scholar
- Wang L, Hauser ER, Shah SH, Pericak-Vance MA, Haynes C, Crosslin D et al (2007) Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet 80(4):650–663. https://doi.org/10.1086/512981 CrossRefPubMedPubMedCentralGoogle Scholar
- Yuan M, Zhan Q, Duan X, Song B, Zeng S, Chen X et al (2013) A functional polymorphism at miR-491-5p binding site in the 3′-UTR of MMP-9 gene confers increased risk for atherosclerotic cerebral infarction in a Chinese population. Atherosclerosis 226(2):447–452. https://doi.org/10.1016/j.atherosclerosis.2012.11.026 CrossRefPubMedGoogle Scholar